comparemela.com

Latest Breaking News On - Therapeutics limited - Page 4 : comparemela.com

Further CYP-001 GvHD Clinical Data Published in Nature Medicine

/PRNewswire/ Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics,.

New south walesCymerus mscsCynata cymerusJohn raskoKilian kellyStem cell therapy programProf rasko is head of departmentAutomic groupUniversity of sydneyCynata therapeutics limitedPrnewswire cynata therapeutics limitedFaculty of medicine healthTherapeutics limitedComplete responseOverall responseNature medicine

Arovella Therapeutics Advances Cancer Cell Therapy

Arovella Therapeutics Limited (AU:ALA) has released an update. Arovella Therapeutics Limited is advancing its unique off-the-shelf iNKT cell therap.

Arovella therapeutics limitedArovella therapeuticsTherapeutics limited

PYC Therapeutics Issues Stock Options

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics, a clinical-stage biotech firm, has issued options as part of its strate.

Therapeutics limited

Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement

/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA) (Kazia or the company) received a letter on May 22, 2024 from Nasdaq notifying the Company that,.

United statesNew south walesKazia therapeutics limitedNasdaq hearings panel theKazia therapeutics limited the companyExchange commissionKazia therapeuticsPrnewswire kazia therapeutics limitedTherapeutics limitedMinimum bid price requirementMinimum bid priceListing qualifications staffNasdaq stock marketNasdaq listing ruleBid priceSecond compliance period

Cynata Reports Breakthrough GvHD Treatment Results

Cynata Therapeutics Limited (AU:CYP) has released an update. Cynata Therapeutics Limited has reported promising two-year survival data for its CYP-.

Cynata therapeutics limitedCynata therapeuticsTherapeutics limited

vimarsana © 2020. All Rights Reserved.